Sorrento Therapeutics revenue

Sorrento Therapeutics revenue decreased from $151.9 million in 2017 to $21.2 million in 2018, a 86% decrease.

Annual Revenue ($)

Sorrento Therapeutics revenue was $21.19 m in FY, 2018

Quarterly Revenue ($)

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018
Revenue$460.15 k$3.83 m$4.59 m$8.15 m$151.86 m$21.19 m
Growth731.25%20%77.6%
Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019
Revenue$83.79 k$976 k$775 k$1.28 m$977 k$1.17 m$1.10 m$988 k$902 k$2.24 m$4.87 m$4.67 m$121.91 m$6.25 m$3.91 m$4.11 m$6.14 m

Annual Growth Rate (%)